Calcicludine

From WikiMD's WELLNESSPEDIA


Calcicludine is a protein derived from the venom of the Green mamba snake (Dendroaspis angusticeps). It belongs to the family of calcium channel blockers, specifically targeting the L-type calcium channels. Calcicludine is known for its potent effect on calcium signaling pathways, which play a crucial role in muscle contraction, neuronal activity, and various cellular functions.

Structure[edit]

Calcicludine is a small protein composed of approximately 60 amino acids. It features a typical knottin fold, which is characteristic of many venom-derived peptides, providing stability and resistance to degradation.

Mechanism of Action[edit]

The primary action of calcicludine is the inhibition of L-type calcium channels. By binding to these channels, calcicludine blocks the influx of calcium ions into cells, which can modulate muscular and neuronal activities. This blocking action is crucial in the context of its potential therapeutic applications, particularly in conditions characterized by excessive calcium ion activity.

Pharmacological Effects[edit]

In pharmacological studies, calcicludine has shown potential as a therapeutic agent in treating conditions such as hypertension, cardiac arrhythmia, and possibly neurological disorders that involve dysregulated calcium ion flow. Its ability to specifically target L-type calcium channels makes it a candidate for precision medicine approaches in these areas.

Research and Applications[edit]

Research on calcicludine is ongoing, with studies focusing on its potential applications in medicine, particularly in cardiovascular and neurological diseases. Its specificity for L-type calcium channels offers a promising avenue for the development of new drugs that are more selective and have fewer side effects than existing calcium channel blockers.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.